Background: Tennis elbow, also known as lateral epicondylitis, is the inflammatory status of insertion site of common extensor tendon to humerus. It is usually related to overuse of local muscle. Radial extracorporeal shock wave therapy (rESWT) is a non-invasive physical treatment. It applies shockwave energy to the lesion site, enhancing the growth of microvascularity, inducing tissue repair, and thus relieving the symptom. The purpose of this study is to understand the therapeutic effect of rESWT to tennis elbow. Material and Methods * Subjects: 30 patients will be recruited from outpatient department of physical medicine and rehabilitation department. * Duration: 2013.09.01-2015.05.31 * Methods: The patients will be randomly divided into the experimental group and the control group through the draw, with 15 patients in each group. Patients in the experimental group receive rESWT plus routine rehabilitation program. Patients in the control group receive sham shockwave therapy plus routine rehabilitation program. * Assessment: Before the therapy starts, patients who match the inclusion criteria will be evaluated using tools mentioned below: * General data: age, sex, body height, body weight, affected side, medical history * Assess upper extremity function and symptom with Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH) * Assess severity of pain with Visual Analogue Scale (VAS) * Assess grip strength with grip strength dynamometer * Measure the size of tear (if any) of common extensor tendon through ultrasonography, and assess the texture of common extensor tendon through real-time sonoelastography (RTS) Patients will be followed up 6 weeks, 3months, and 6 months after therapy starts. They will be re-assessed of upper extremity function and symptom, severity of pain, grip strength, and presentation on ultrasonography and RTS.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Changes in pain intensity
Timeframe: At baseline, 6 weeks, 12 weeks and 24 weeks
Changes in grip strength
Timeframe: At baseline, 6 weeks, 12 weeks and 24 weeks
Changes in upper limb function
Timeframe: At baseline, 6 weeks, 12 weeks and 24 weeks
Changes in stiffness of common extensor tendon
Timeframe: At baseline, 6 weeks, 12 weeks and 24 weeks